tiprankstipranks
Advertisement
Advertisement

Aptorum Group Receives Nasdaq Notice Over Minimum Bid Price Deficiency

Story Highlights
  • Aptorum Group disclosed on March 6, 2026 that Nasdaq notified it of non-compliance with the $1 minimum bid price rule, though trading of its shares remains unaffected for now.
  • Nasdaq granted Aptorum Group until September 1, 2026 to regain bid-price compliance, and the company is weighing measures including a possible reverse stock split to protect its listing.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Aptorum Group Receives Nasdaq Notice Over Minimum Bid Price Deficiency

Claim 55% Off TipRanks

Aptorum Group ( (APM) ) just unveiled an update.

On March 6, 2026, Aptorum Group disclosed that it received a Nasdaq notice dated March 5, 2026, indicating non-compliance with the exchange’s minimum bid price requirement of $1 per share under Listing Rule 5550(a)(2). The notification does not immediately impact the listing or trading of its shares, but it places the company under closer scrutiny regarding its market valuation.

Nasdaq has granted Aptorum Group a 180-day grace period, until September 1, 2026, to regain compliance with the bid-price rule, giving management time to address the deficiency. During this window the company plans to evaluate options including a potential reverse stock split, signaling a proactive stance to preserve its Nasdaq listing and reassure investors concerned about delisting risk.

The most recent analyst rating on (APM) stock is a Hold with a $0.81 price target. To see the full list of analyst forecasts on Aptorum Group stock, see the APM Stock Forecast page.

Spark’s Take on APM Stock

According to Spark, TipRanks’ AI Analyst, APM is a Neutral.

The score is driven primarily by weak financial performance, marked by zero recent revenue, ongoing losses, and negative cash flow. Technical indicators also point to a sustained downtrend (price below key moving averages and negative MACD), while valuation is constrained by a negative P/E and no dividend yield data.

To see Spark’s full report on APM stock, click here.

More about Aptorum Group

Aptorum Group Limited is a pharmaceutical and biotechnology company focused on discovering, developing and commercializing therapeutic assets to treat diseases with unmet medical needs. The company is listed on Nasdaq under the ticker APM and operates globally, with principal executive offices in London and operations referenced in Hong Kong.

Average Trading Volume: 49,497

Technical Sentiment Signal: Strong Sell

Current Market Cap: $6.52M

See more data about APM stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1